Tus kws kho mob
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2621 - 2630 ntawm 4269
Tus kws kho mob
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 28, 2016
Tus kws kho mob
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024